Paul J. Glazer Discloses 2.47M-Share Position in scPharmaceuticals (4.64%)

Rhea-AI Filing Summary

Glazer Capital, LLC and its managing member Paul J. Glazer filed a Schedule 13G reporting shared voting and dispositive power over 2,474,820 shares of scPharmaceuticals Inc. common stock, representing 4.64% of the class. The filing states the shares are held by funds and managed accounts for which Glazer Capital is investment manager and that the position is not held to influence control of the issuer. The reporting persons provide their business address in New York and identify Glazer Capital as a Delaware LLC and Paul J. Glazer as a U.S. citizen. The filing notes that the reporting persons previously may have been deemed to own more than 5% but have ceased to be beneficial owners of more than five percent as of the date of this statement.

Positive

• Transparent disclosure of ownership: reporting of 2,474,820 shares (4.64%) provides clarity to the market
• Passive position affirmed: filing states shares are not held to influence or change issuer control

Negative

• None.

Insights

Securities Analyst

TL;DR: Passive disclosure: a 4.64% shared stake reported, consistent with an investment-adviser filing under Schedule 13G.

The Schedule 13G shows Glazer Capital serves as investment manager to funds and managed accounts holding 2,474,820 shares of scPharmaceuticals Inc., with shared voting and dispositive power but no sole voting or dispositive power. Classification codes (IA, OO for the entity; IN for the individual) indicate an investment adviser filing and an individual investor disclosure. The filing explicitly states the position is not intended to change or influence issuer control, which aligns with passive investor treatment under Rule 13d-1. The note that the reporting persons "ceased to be the beneficial owner of more than five percent" is administratively important because it affects filing status and market signaling about position sizing.

Corporate Governance Specialist

TL;DR: Governance implications are limited: shared voting power exists, but the filing affirms a non-control, passive stake.

The document discloses shared voting and dispositive power for 2,474,820 shares but explicitly denies intent to influence control, reducing immediate governance concerns. Because no sole voting or dispositive power is reported, the filing does not indicate an attempt to direct board or strategic change. The prior reference to having been over 5% and then falling below that threshold is noteworthy for governance monitoring because crossing those thresholds can trigger changes in disclosure obligations and market perception, yet current ownership remains below the 5% materiality threshold.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

scPharmaceuticals Inc.

(Name of Issuer)

Common stock, par value $0.0001 per share

(Title of Class of Securities)

810648105

(CUSIP Number)

09/02/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 810648105

1

Names of Reporting Persons

Glazer Capital, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 2,474,820.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 2,474,820.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,474,820.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.64 %

12

Type of Reporting Person (See Instructions)

IA, OO

SCHEDULE 13G

CUSIP No. 810648105

1

Names of Reporting Persons

Paul J. Glazer

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 2,474,820.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 2,474,820.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,474,820.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.64 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: scPharmaceuticals Inc.
(b)	Address of issuer's principal executive offices: 25 Mall Road, Suite 203, Burlington, Massachusetts, 01803
Item 2.
(a)	Name of person filing: This statement is filed by: (i) Glazer Capital, LLC, a Delaware limited liability company ("Glazer Capital"), with respect to the shares of Common Stock (as defined in Item 2(d)) held by certain funds and managed accounts to which Glazer Capital serves as investment manager (collectively, the "Glazer Funds"); and (ii) Mr. Paul J. Glazer ("Mr. Glazer"), who serves as the Managing Member of Glazer Capital, with respect to the shares of Common Stock held by the Glazer Funds. The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons." The filing of this statement should not be construed as an admission that any of the Reporting Persons is, for the purposes of Section 13 of the Act, the beneficial owner of the shares of Common Stock (as defined in Item 2(d)) reported herein.
(b)	Address or principal business office or, if none, residence: The address of the business office of each of the Reporting Persons is 250 West 55th Street, Suite 30A, New York, New York 10019.
(c)	Citizenship: Glazer Capital is a Delaware limited liability company. Mr. Glazer is a United States citizen.
(d)	Title of class of securities: Common stock, par value $0.0001 per share
(e)	CUSIP No.: 810648105
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 2,474,820
(b)	Percent of class: 4.64%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 2,474,820
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 2,474,820
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. The Reporting Persons may have been deemed to beneficially own more than 5% of the outstanding shares on the date of event that required the filing of the Schedule 13G. As of the date hereof, the Reporting Persons have ceased to be the beneficial owner of more than five percent of the class of securities.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Glazer Capital, LLC

Signature:	Paul J. Glazer
Name/Title:	Paul J. Glazer, Managing Member
Date:	09/09/2025

Paul J. Glazer

Signature:	Paul J. Glazer
Name/Title:	Paul J. Glazer
Date:	09/09/2025

FAQ

What stake in scPharmaceuticals Inc. (symbol provided) do Glazer Capital and Paul J. Glazer report?

They report shared voting and dispositive power over 2,474,820 shares, representing 4.64% of the class.

Is the position reported as an attempt to influence control of the issuer?

No; the filing certifies the securities were not acquired and are not held for the purpose of changing or influencing control.

Who holds the shares on behalf of Glazer Capital?

The shares are held by certain funds and managed accounts for which Glazer Capital acts as investment manager (collectively, the Glazer Funds).

Do the reporting persons claim sole voting or dispositive power over the shares?

No; the filing reports 0 shares with sole voting or dispositive power and 2,474,820 shares with shared voting and dispositive power.

Has Glazer Capital ever exceeded 5% ownership of the class?

The filing states the reporting persons "may have been deemed to beneficially own more than 5%" on the event date but that they have ceased to be beneficial owners of more than five percent as of the filing date.